Updated: Medicare weighs changes to controversial plan on cancer meds

WASHINGTON — Trying to salvage a controversial experiment to confront rising drug costs, the Obama administration Tuesday hinted at modifications to an ambitious plan that would revamp Medicare payments. Affected are those medications administered in a doctor’s office. That includes most chemotherapy drugs, as well as injected and infused drugs for macular degeneration, rheumatoid arthritis, […]